At a glance
ClinicalIndex Comparison RecordN/ACompleted· 754 enrolled
Drug / intervention
CorPath-assisted Percutaneous Coronary Interventionprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Post-Market Registry for the Evaluation of the CorPath 200 System Effectiveness in Percutaneous Coronary Interventions
In Brief
An observational study evaluating CorPath-assisted Percutaneous Coronary Intervention for Coronary Artery Disease and 7 related conditions. Completed, enrolled 754 participants across 16 sites in 2 countries.
Detailed Summary
To collect data on the routine patterns of use, safety and effectiveness, including the clinical and technical performance of the CorPath 200 System, in the delivery and manipulation of coronary guidewires and stent/balloon catheters during PCI procedures.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease, Coronary Disease, Myocardial Ischemia, Heart Diseases, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Vascular Diseases
CountriesIsrael, United States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartAug 2013
First PostedAug 2013
Primary CompletionDec 2016
TodayJul 2026
First PostedAug 7, 2013
Enrollment StartAug 1, 2013
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 12.9 years ago
Interventions
CorPath-assisted Percutaneous Coronary Interventionprocedure
Robotic-assisted Percutaneous Coronary Intervention